Peter Damman

Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity

Tim P. van de Hoef, Martijn A. van Lavieren, Peter Damman et al. · Circulation Cardiovascular Interventions · 2014 · 375 citations

Medicine, Cardiology, Clinical Cardiology +16

A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction

Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt et al. · Circulation · 2022 · 148 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

5-Year Clinical Outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) Trial

Peter Damman, Alexander Hirsch, Fons Windhausen et al. · Journal of the American College of Cardiology · 2010 · 132 citations

Medicine, Cardiology, Internal Medicine +15

Impact of hyperaemic microvascular resistance on fractional flow reserve measurements in patients with stable coronary artery disease: insights from combined stenosis and microvascular resistance assessment

Tim P. van de Hoef, Froukje Nolte, Mauro Echavarría‐Pinto et al. · Heart · 2014 · 124 citations

Medicine, Cardiology, Nuclear Medicine +17

Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction

Peter Damman, Marcel A.M. Beijk, Wichert J. Kuijt et al. · Journal of the American College of Cardiology · 2010 · 101 citations

Medicine, Cardiology, Internal Medicine +16